{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreiewvbjtsbhwlzpfpz6h4wdav4rwmcncxjmrztet7k2chtrsbutrf4",
    "uri": "at://did:plc:5ka4qkui7nvjms7idhte2m4o/app.bsky.feed.post/3mntn2qjwef62"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreihs4yniv5gslv4xxwpwazmdqvpsj3sble4olz6hvbzdguafle3ihy"
    },
    "mimeType": "image/jpeg",
    "size": 123080
  },
  "path": "/pharmalot/2026/06/08/lilly-pfizer-obesity-drug-trial-data-roche-deal/?utm_campaign=rss",
  "publishedAt": "2026-06-08T13:28:35.000Z",
  "site": "https://www.statnews.com",
  "tags": [
    "Pharma",
    "Pharmalot",
    "pharmalittle",
    "STAT+"
  ],
  "textContent": "Lilly disclosed new data that provide more details on the safety and tolerability of its next-generation obesity drug retatrutide",
  "title": "STAT+: Pharmalittle: We’re reading about Lilly and Pfizer obesity drug data, Roche and J&J deals, and more",
  "updatedAt": "2026-06-08T13:28:40.000Z"
}